Debut Plus

440.6

-1.15 -0.26%

17 Jul 2026

NSE Listed

ASM 1

Cohance Lifesciences Ltd. (COHANCE)

Volume: 3,99,035Avg Vol 1W: 3,82,868Avg Vol 1M: 6,05,57952W Range:266.71,121.15
Key Ratios
Checked 6h ago
Market Cap₹15,406 Cr
Current Price₹440.6
Previous Close₹441.75
High / Low (52w)₹1,121.15 / ₹266.7
Volume3,99,035
Avg Vol (1W)3,82,868
Avg Vol (1M)6,05,579
Stock P/E108.7
Book Value₹90.95
Dividend Yield
ROE12.5%
ROA
Revenue (TTM)₹1,256 Cr
Revenue Growth
Profit Margin
Total Debt₹6 Cr
Shares Outstanding
Face Value₹1
EPS (TTM)₹10.67
P/B12.75
Debt / Equity0.04
50 DMA₹436.88
200 DMA₹475.96
Day change-0.26%
SurveillanceASM 1 (as of 2026-07-11)
Price Chart
440.6 59.84% · 1Y
10972804.8Cr
2025-07-17
2026-07-16

20-day avg volume: 6.1L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 17% YoY.
  • Stock trades at a high P/E of 109.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹488 Cr₹604 Cr₹676 Cr₹840 Cr₹549 Cr₹556 Cr₹545 Cr₹619 Cr
EBITDA₹113 Cr₹184 Cr₹215 Cr₹187 Cr₹81 Cr₹93 Cr₹55 Cr₹46 Cr
Net Profit₹75 Cr₹138 Cr₹153 Cr₹120 Cr₹49 Cr₹74 Cr₹37 Cr₹20 Cr
EPS
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹378 Cr₹852 Cr₹1,024 Cr₹1,413 Cr₹1,387 Cr₹1,113 Cr₹1,256 Cr
EBITDA₹161 Cr₹376 Cr₹423 Cr₹633 Cr₹565 Cr₹413 Cr₹356 Cr
Net Profit₹109 Cr₹317 Cr₹362 Cr₹454 Cr₹411 Cr₹300 Cr₹268 Cr
EPS8.5912.4514.2317.8316.1611.810.45
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹783 Cr₹1,173 Cr₹1,474 Cr₹1,830 Cr₹1,966 Cr₹2,254 Cr₹3,032 Cr
Total Liabilities₹193 Cr₹328 Cr₹294 Cr₹302 Cr₹231 Cr₹203 Cr₹1,191 Cr
Equity₹590 Cr₹845 Cr₹1,181 Cr₹1,527 Cr₹1,735 Cr₹2,051 Cr₹1,841 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹83 Cr₹493 Cr₹492 Cr₹514 Cr₹603 Cr₹468 Cr₹372 Cr
Investing₹-65 Cr₹-413 Cr₹-311 Cr₹-136 Cr₹-195 Cr₹-362 Cr₹-255 Cr
Financing₹26 Cr₹7 Cr₹-76 Cr₹-156 Cr₹-242 Cr₹-14 Cr₹3 Cr
Free Cash Flow₹83 Cr₹493 Cr₹492 Cr₹514 Cr₹603 Cr₹468 Cr₹372 Cr
Shareholding
Promoter 57.49% Institutions 27.38% Public 15.13%
Efficiency & Working Capital
ROCE5.5%
Interest Coverage25.5
Dividend Payout
Debtor Days87 d
Inventory Days51 d
Payable Days24 d
Cash Conversion Cycle113 d
Working Capital Days137 d
Shareholding Details

As of 2026-03-31

Promoter57.5%
FII5.6%
DII21.8%
Institutions27.4%
Public15.1%
Promoter Pledge100%
No. of Shareholders85,230
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025May 2025May 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters60%50.1%50.1%50.1%50.1%50.1%66.4%66.4%66.4%57.5%57.5%57.5%
FIIs10.1%9.5%9.8%10.7%10.8%11%7.4%7.4%7.2%6.5%6%5.6%
DIIs15.9%17.2%17.4%16.9%16.7%16.6%11%11%11.4%20.8%21.6%21.8%
Public13.9%23.1%22.7%22.3%22.4%22.2%15.2%15.2%15%15.2%14.9%15.1%
Promoter Pledge0%0%0%0%0%0%0%0%100%100%100%100%
No. of Shareholders70,05268,93265,77769,33784,21086,32588,65888,65880,91075,28481,87785,230
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Berhyanda LimitedShareholding of Promoter and Promoter Group33.3%12.75 Cr
Jusmiral Holdings LimitedShareholding of Promoter and Promoter Group24.2%9.24 Cr
Dsp Nifty Smallcap 250 EtfPublic Shareholding4.8%1.82 Cr
Icici Prudential Value FundPublic Shareholding4.5%1.72 Cr
Jasub Property Holdings LlpPublic Shareholding3.8%1.47 Cr
Hdfc Mutual Fund - Hdfc Bse 500 EtfPublic Shareholding3.1%1.20 Cr
Jasti Property And Equity Holdings Private LimitedPublic Shareholding2.5%96,16,009
Sbi Life Insurance Co. LtdPublic Shareholding2%77,25,076
Invesco India Contra FundPublic Shareholding1.4%54,90,268
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Berhyanda Limited12.75 Cr100%2026-03-31
Jusmiral Holdings Limited9.24 Cr100%2026-03-31
Icici Prudential Value Fund00%2026-03-31
Dsp Nifty Smallcap 250 Etf00%2026-03-31
Hdfc Mutual Fund - Hdfc Bse 500 Etf00%2026-03-31
Invesco India Contra Fund00%2026-03-31
Sbi Life Insurance Co. Ltd00%2026-03-31
Jasti Property And Equity Holdings Private Limited00%2026-03-31
Jasub Property Holdings Llp00%2026-03-31
Berhyanda Limited12.75 Cr100%2025-12-31
Jusmiral Holdings Limited9.24 Cr100%2025-12-31
Icici Prudential Equity & Debt Fund00%2025-12-31
Board of Directors
NameDesignationYear
Vivek SharmaChairman & Exec. Director2025
Vinod PadikkalNon-Exec & Non-Independent Dir2025
K G AnanthakrishnanIndependent Non Exe. Director2025
Matangi GowrishankarIndependent Non Exe. Director2025
Vinod RaoIndependent Non Exe. Director2025
U B Pravin RaoIndependent Non Exe. Director2025
Jaishankar KrishnanIndependent Non Exe. Director2025
Pankaj PatwariNon Executive Director2025
Shweta JalanNon Executive Director2025
KUNDAN KUMAR JHACS / Compliance Officer / Legal Head2025
Himanshu AgarwalWhole Time Director & Chief Financial Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing of Bulk Drugs & Inter₹0 Cr
Segments — Geography
RegionRevenueShare
USA₹173 Cr16.2%
Europe₹748 Cr70%
India₹72 Cr6.7%
Others₹76 Cr7.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1402525
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202520025027
2025000707
202500018018
Insider / Designated-Person Trades

7 recent disclosure(s)

Jusmiral Holdings LimitedDisposal · 3,41,48,000
Dr. Venkata Naga Kali Vara Prasada Raju VetukuriDisposal · 6,00,000
Dr. Venkata Naga Kali Vara Prasada Raju VetukuriAcquisition · 7,13,259
Jusmiral Holdings LimitedAcquisition · 12,65,38,578
JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED in its capacity as sole Trustee of the Jasti Family TrustDisposal · 12,75,37,043
PADMAJA J.A.SDisposal · 28,000
Substantial Acquisitions (SAST)

18 disclosure(s)

Inter-se Transfer23/02/2026 · 77,00,000
Inter-se Transfer18/02/2026 · 70,00,000
Market18/02/2026 · 78,76,948
Release Of Encumbrances18/09/2025 ·
Market18/09/2025 · 3,41,48,000
Encumbrance Created09/05/2025 ·
Company Information
Incorporated2018
ChairmanVivek Sharma
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]
🌐 www.suvenpharm.com

📍 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5, Hyderabad, Telangana, 500034

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search